Checkpoint Inhibitor-Associated Vogt-Koyanagi-Harada Disease Presenting 3 Months Following Discontinuation of Nivolumab
The use of checkpoint inhibitors has been associated with multiple ocular and orbital complications including Vogt-Koyanagi-Harada disease. In the current case, a 55-year-old man presented with visual changes 3 months following discontinuation of nivolumab for metastatic renal cell carcinoma. This i...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Ophthalmic surgery, lasers & imaging retina. - 2013. - 54(2023), 3 vom: 15. März, Seite 183-187
|
|---|
| 1. Verfasser: |
Tieger, Marisa Gobuty
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Eliott, Dean,
Cakir, Bertan,
Dahrouj, Mohammad |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2023
|
|---|
| Zugriff auf das übergeordnete Werk: | Ophthalmic surgery, lasers & imaging retina
|
|---|
| Schlagworte: | Case Reports
Journal Article
Nivolumab
31YO63LBSN
Immune Checkpoint Inhibitors |
|---|